{"id":"NCT03010631","sponsor":"Sucampo Pharma Americas, LLC","briefTitle":"Comparative Pharmacokinetics and Food-Effect Bioavailability of Lubiprostone Sprinkle in Healthy Volunteers","officialTitle":"Comparative Pharmacokinetics and Food-Effect Bioavailability of a Sprinkle Formulation of Lubiprostone After Oral Administration in Healthy Volunteers","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-11-16","primaryCompletion":"2016-12-23","completion":"2017-05","firstPosted":"2017-01-05","resultsPosted":"2020-03-09","lastUpdate":"2020-03-09"},"enrollment":49,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Healthy Volunteers"],"interventions":[{"type":"DRUG","name":"Cohort 1: Lubiprostone Capsule, Fasted","otherNames":["AMITIZAÂ®","Treatment A"]},{"type":"DRUG","name":"Cohort 1: Lubiprostone Sprinkle Formulation, Fasted","otherNames":["Lubiprostone microbeads","Treatment B"]},{"type":"DRUG","name":"Cohort 2: Lubiprostone Sprinkle Formulation, Fed","otherNames":["Lubiprostone microbeads","Treatment C"]},{"type":"DRUG","name":"Cohort 2: Lubiprostone Sprinkle Formulation, Fasted","otherNames":["Lubiprostone microbeads","Treatment D"]}],"arms":[{"label":"Cohort 1 (Treatment Sequence AB)","type":"ACTIVE_COMPARATOR"},{"label":"Cohort 1 (Treatment Sequence BA)","type":"EXPERIMENTAL"},{"label":"Cohort 2 (Treatment Sequence CD)","type":"EXPERIMENTAL"},{"label":"Cohort 2 (Treatment Sequence DC)","type":"EXPERIMENTAL"}],"summary":"A study to compare the pharmacokinetics and food-effect bioavailability of sprinkle formulation of lubiprostone, as compared to lubiprostone capsules in healthy volunteers.","primaryOutcome":{"measure":"Cohort 1: Area Under the Concentration-time Curve (AUC) From Hour 0 to the Last Measurable Concentration (AUC0-t) of M3 Metabolite","timeFrame":"1 day","effectByArm":[{"arm":"Treatment A: Lubiprostone Capsule, Fasted","deltaMin":117.518,"sd":57.56},{"arm":"Treatment B: Sprinkle Formulation, Fasted","deltaMin":163.615,"sd":47.45}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":2,"exclusionCount":5},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["33834354"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":31},"commonTop":["Diarrhoea","Nausea","Abdominal pain","Headache","Dizziness"]}}